Skip to main content
. 2019 Dec;7(24):810. doi: 10.21037/atm.2019.12.63

Table S2. The power calculation for the detected normalized intensity difference of candidate genes.

Gene symbol Non-hypoxemic Hypoxemic Mean difference Alpha
(significance level)
Beta Power (1-beta)
N Normalized intensity (mean ± SD) N Normalized intensity (mean ± SD)
NLRP3 6 7.649±0.714 9 9.25±1.157 1.601 0.05 0.065 0.935
PSMA5 6 12.14±0.823 9 13.67±0.902 1.53 0.05 0.058 0.942
CLEC4D 6 9.278±1.606 9 11.76±1.707 2.518 0.05 0.135 0.865
SOS1 6 6.216±1.43 9 7.976±1.039 1.76 0.05 0.223 0.777
CD300A 6 9.462±1.354 9 10.91±0.7057 1.448 0.05 0.293 0.706
ELF1 6 9.278±1.077 9 11.05±0.9506 1.772 0.05 0.077 0.923
PRKD2 6 7.868±1.311 9 9.487±0.9846 1.619 0.05 0.225 0.775
STAT3 6 8.687±0.950 9 10.05±0.673 1.363 0.05 0.121 0.879
PSMA2 6 10.18±1.062 9 11.82±0.986 1.64 0.05 0.116 0.883

The power calculation for the detected normalized intensity difference of candidate genes between groups with the present sample size was performed by Power Analysis and Sample Size (PASS) software (PASS 2008. NCSS, LLC. Kaysville, Utah, USA). For the current sample size of 9 in septic group with hypoxemia and 6 in that without and the detected normalized intensity difference of candidate genes, the detailed variables were set as above. Normalized intensity values were recorded from the microarray analysis. Mean difference = Mean (Hypoxemic) - Mean (Non-hypoxemic). The Alpha value of 0.05, as a level of significance was applied for estimation. The value of beta and respective power were obtained from power analysis of a non-Inferiority test of the difference of two means by PASS.